285-288
Commentary
Open AccessToward the harmonization of immune monitoring in clinical trials: Quo vadis?
C. M. Britten, S. Janetzki, S. H. van der Burg, C. Gouttefangeas and A. Hoos
289-302
Original Article
Open AccessThe CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
C. M. Britten, C. Gouttefangeas, M. J. P. Welters, G. Pawelec and S. Koch, et al.
303-315
Original Article
Open AccessResults and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
Sylvia Janetzki, Katherine S. Panageas, Leah Ben-Porat, Jean Boyer and Cedrik M. Britten, et al.
317-323
Original Article
Plant-derived EpCAM antigen induces protective anti-cancer response
Robert Brodzik, Sergei Spitsin, Max Golovkin, Katarzyna Bandurska and Carla Portocarrero, et al.
325-336
Original Article
Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression
Heriberto Prado-Garcia, Dolores Aguilar-Cazares, Manuel Meneses-Flores, Jorge Morales-Fuentes and Jose Sullivan Lopez-Gonzalez
337-345
Original Article
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer
Tetsuro Uchida, Shigetoshi Horiguchi, Yuriko Tanaka, Heizaburo Yamamoto and Naoki Kunii, et al.
347-358
Original Article
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells
Elizabeth P. Ryan, Timothy P. Bushnell, Alan E. Friedman, Irfan Rahman and Richard P. Phipps
359-366
Original Article
Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion
Antonia Teruel, Marcela Romero, Nicholas A. Cacalano, Christian Head and Anahid Jewett
367-378
Original Article
Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning
Qing-An Yuan, Matthew K. Robinson, Heidi H. Simmons, Maria Russeva and Gregory P. Adams
379-388
Original Article
Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity
Maria Liljefors, Bo Nilsson, Håkan Mellstedt and Jan-Erik Frödin
389-398
Original Article
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes
James A. Thompson, Minu K. Srivastava, Jacobus J. Bosch, Virginia K. Clements and Bruce R. Ksander, et al.
399-409
Original Article
CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients
Sofia Vikman, Valeria Giandomenico, Roberta Sommaggio, Kjell Öberg and Magnus Essand, et al.
411-423
Original Article
Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells
Tina Müller, Christoph Uherek, Guitta Maki, Kai Uwe Chow and Annemarie Schimpf, et al.
425-439
Original Article
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
Natalie Kronik, Yuri Kogan, Vladimir Vainstein and Zvia Agur
441
Erratum
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
Natalie Kronik, Yuri Kogan, Vladimir Vainstein and Zvia Agur